Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation

NCT03304431 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Lidocaine Causing Adverse Effects in Therapeutic Use
Tracheal Intubation Morbidity

Interventions

DRUG: Orotracheal Lidocaine Oral Spray application

Sponsor

Abant Izzet Baysal University